findmyKOL
Clinical trialNCT00611130CompletedPhase 2Interventional

Vigabatrin for Treatment of Cocaine Dependence

SponsorCatalyst Pharmaceuticals, Inc.Enrollment186Cocaine Dependence
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The objective of this study is to demonstrate that a larger proportion of vigabatrin-treated subjects than placebo-treated subjects will be cocaine-free in the last 2 weeks of treatment.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Addiction Treatment Clinic

    Little Rock, Arkansas, United States

  • St. Luke'S Hospital Addiction Pharmacology Research Laboratory

    San Francisco, California, United States

  • Friends Research Institute

    Torrance, California, United States

  • Operation Par

    Largo, Florida, United States

  • Segal Institute for Clinical Research

    North Miami, Florida, United States

  • Johns Hopkins Bayview Medical Center Center for Chemical Dependence

    Baltimore, Maryland, United States

  • Boston University School of Medicine

    Boston, Massachusetts, United States

  • New York University Mental Health and Addictive Disorders Research Program

    New York, New York, United States

  • Cincinnati Addiction Research Center (cinarc)

    Cincinnati, Ohio, United States

  • Dayton Veterans Affairs Medical Center

    Dayton, Ohio, United States

  • University of Texas Health Science Center at San Antonio

    San Antonio, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

PlaceboVigabatrin →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jan 2008
Primary completion
31 May 2009
Completion
31 Oct 2012
Last update posted
13 Apr 2016
Registered enrollment
186
Registry id
NCT00611130
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.